Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Redeye: Dignitana Q4’22 - Underlying positive momentum

Dignitana

Redeyes’ view on Dignitana is generally unchanged. We see that the sales momentum continued in the quarter, which could have been even higher without the component issues that hampered sales a bit. A write-down negatively affected the gross margin; however, the underlying gross margin was in the normal range. The US market is transforming, and we believe there is more to come which supports the long-term growth case in Dignitana. The development over quarters can vary, but the trend is positive. We lower our very high expectation on growth for 2023e to high. With the estimate adjustments, we adjust our fair value range to SEK 5 (7) to SEK 22 (24) per share and a Base case value of SEK 12 (15) per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Dignitana Q4’22 - Underlying positive momentum

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.